FDA approves HERNEXEOS®, the first targeted therapy for adults with HER2

This press release is not intended for UK media HERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as demonstrated in the Beamion LUNG-1 clinical trial1 Accelerated approval follows Breakthrough Therapy Designation and prior FDA approval for previously treated patients in August 2025 Ingelheim, Germany and Ridgefield, Conn. [DATE] — The […]


1 w.
Science
ID: -8496543467897356806


Similar News expand_more


Science
Science
Science
Science
Technology
Science
Science
Science
Science
Science
Science
Science
Science
Technology
Science
Science
Technology
Science
Technology
Technology
Science
Crime
Economics
Science
Science
Science
Science
Science
Science
Science
Technology
Crime
Science
Sport
Science
Science
Crime
Science
Technology
Science
Education
Science
Crime
Technology
Technology
Science
Science
Science
Crime
Popular

Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down